Sign up for our daily Newsletter and stay up to date with all the latest news!

Subscribe I am already a subscriber

You are using software which is blocking our advertisements (adblocker).

As we provide the news for free, we are relying on revenues from our banners. So please disable your adblocker and reload the page to continue using this site.
Thanks!

Click here for a guide on disabling your adblocker.

Sign up for our daily Newsletter and stay up to date with all the latest news!

Subscribe I am already a subscriber

CAN (ON): CannaRoyalty completes $5 million financing

CannaRoyalty announces that one of its investee companies Resolve Digital Health, a medical cannabis delivery system company that develops proprietary smart technology, has completed a $5 million Series A financing round led by Canadian TSX-listed company and ACMPR Licensed Producer, Aphria together with participation by CannaRoyalty which will now own 27.2% of the existing shares of Resolve on a non-diluted basis, a holding with an implied value of approximately $7.1 million based on the financing price.

“We are breaking new ground with the strides taken over the last two years to completely rethink the medical cannabis experience with a patient-centric approach that is measurable and trackable at the heart of our strategy,” said Rob Adelson, Founder and CEO of Resolve Digital Health. “The advancements made thus far would not have been possible without the support and collaboration from Marc and the team at CannaRoyalty, which are even stronger today with our new partner, Aphria.”

From its initial investment in October 2015, CannaRoyalty saw the immediate opportunity in Resolve. Through multiple share acquisitions, including C$80,000 invested in this financing, CannaRoyalty has acquired a substantial ownership position in Resolve and provided seed capital and resources for the research and development of Resolve’s unique medical device system, Breeze. Unlike many existing cannabis products, Breeze is unique in that it provides an accurate, metered, treatment solution with pre-packaged, single use pods filled with the highest quality cannabis buds or oil, making it easy and safe for end-users.

“We are thrilled about participating in the closing of this financing. It provides third party validation of our initial investment in Resolve at a significantly higher valuation,” said Marc Lustig, CEO of CannaRoyalty. “It is an example of the success of our business model that includes identifying high-value cannabis assets, partnering through investment and assisting in the growth and commercialization of brands, products and devices – while increasing value for our shareholders.”

For more information:
CannaRoyalty
333 Preston Street, Suite 610, Ottawa, ON, K1S 5N4
1-844-556-5070
613 680 5070
info@cannaroyalty.com
www.cannaroyalty.com

Publication date: